Naringin attenuates enhanced cough, airway hyperresponsiveness and airway inflammation in a guinea pig model of chronic bronchitis induced by cigarette smoke

International Immunopharmacology

Volumn 13, Issue 3, 2012, Pages 301-307

  Luo, Yu Long ^a   Zhang, Chen Chen ^a   Li, Pei Bo ^a   Nie, Yi Chu ^a   Wu, Hao ^b   Shen, Jian Gang ^b   Su, Wei Wei ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b THE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Airway hyperresponsiveness; Anti inflammation; Cough; Lipoxin A4; Naringin; Smoke

Indexed keywords

AURANTIIN; CIGARETTE SMOKE; INTERLEUKIN 8; LEUKOTRIENE B4; LIPOXIN A; MYELOPEROXIDASE; PREDNISONE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASOPHIL; CELL INFILTRATION; CHRONIC BRONCHITIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; COUGHING; DRUG EFFECT; ENZYME ACTIVITY; EOSINOPHIL COUNT; EXPERIMENTAL GUINEA PIG; FEMALE; LUNG LAVAGE; LUNG PARENCHYMA; LYMPHOCYTE COUNT; MALE; MONOCYTE; NEUTROPHIL COUNT; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT INFLAMMATION; TRACHEA INJURY;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTITUSSIVE AGENTS; BRONCHIAL HYPERREACTIVITY; BRONCHITIS, CHRONIC; BRONCHOALVEOLAR LAVAGE FLUID; CHEMOKINES; COUGH; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; FLAVANONES; GUINEA PIGS; HUMANS; MALE; PEROXIDASE; SMOKE; SMOKING; SUPEROXIDE DISMUTASE; TOBACCO;

EID: 84861446574     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2012.04.019     Document Type: Article

References (45)

1. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet 2007;370:765-73. (Pubitemid 47321908)
2. Braman SS. Chronic cough due to chronic bronchitis. Chest 2006;129:104S-15S.
3. Chung KF. Cytokines in chronic obstructive pulmonary disease. Eur Respir J Suppl 2001;34:50s-9s. (Pubitemid 34760609)
4. Planaguma A, Kazani S, Marigowda G, Haworth O, Mariani TJ, Israel E, et al. Airway lipoxin A4 generation and lipoxin A4 receptor expression are decreased in severe asthma. Am J Respir Crit Care Med 2008;178:574-82.
5. Fritscher LG, Rodrigues MT, Sporn H, Balter M, Post M, Zamel N, et al. Profile of eicosanoids in breath condensate in asthma and COPD. Am J Respir Crit Care 2009;179:A5713.
6. Leuenberger P, Schwartz J, Ackermann-Liebrich U, Blaser K, Bolognini G, Bongard JP, et al. Passive smoking exposure in adults and chronic respiratory symptoms (SAPALDIA Study). Swiss Study on Air Pollution and Lung Diseases in Adults, SAPALDIA Team. Am J Respir Crit Care Med 1994;150:1222-8. (Pubitemid 24356632)
7. Pope CR, Xu X. Passive cigarette smoke, coal heating, and respiratory symptoms of nonsmoking women in China. Environ Health Perspect 1993;101:314-6. (Pubitemid 23322325)
8. Mak JC. Pathogenesis of COPD. Part II. Oxidative-antioxidative imbalance. Int J Tuberc Lung Dis 2008;12:368-74. (Pubitemid 351507247)
9. Churg A, Cosio M, Wright JL. Mechanisms of cigarette smoke-induced COPD: insights from animal models. Am J Physiol Lung Cell Mol Physiol 2008;294:L612-31. (Pubitemid 351520094)
10. Wright JL, Churg A. A model of tobacco smoke-induced airflow obstruction in the guinea pig. Chest 2002;121:188S-91S. (Pubitemid 34497338)
11. Wright JL, Cosio M, Churg A. Animal models of chronic obstructive pulmonary disease. Am J Physiol Lung Cell Mol Physiol 2008;295:L1-L15.
12. Morice AH, Fontana GA, Belvisi MG, Birring SS, Chung KF, Dicpinigaitis PV, et al. ERS guidelines on the assessment of cough. Eur Respir J 2007;29:1256-76. (Pubitemid 46895388)
13. Lin BQ, Li PB, Wang YG, Peng W, Wu Z, Su WW, et al. The expectorant activity of naringenin. Pulm Pharmacol Ther 2008;21:259-63. (Pubitemid 351312668)
14. Gao S, Li PB, Yang HL, Fang SQ, Su WW. Antitussive effect of naringin on experimentally induced cough in guinea pigs. Planta Med 2011;77:16-21.
15. Shi Y, Dai J, Liu H, Li RR, Sun PL, Du Q, et al. Naringenin inhibits allergen-induced airway inflammation and airway responsiveness and inhibits NF-kappaB activity in a murine model of asthma. Can J Physiol Pharmacol 2009;87:729-35.
16. Liu Y, Wu H, Nie YC, Chen JL, Su WW, Li PB. Naringin attenuates acute lung injury in LPS-treated mice by inhibiting NF-kappaB pathway. Int Immunopharmacol 2011;11:1606-12.
17. Fujimura M, Kamio Y, Hashimoto T, Matsuda T. Cough receptor sensitivity and bronchial responsiveness in patients with only chronic nonproductive cough: in view of effect of bronchodilator therapy. J Asthma 1994;31:463-72.
18. Lewis CA, Ambrose C, Banner K, Battram C, Butler K, Giddings J, et al. Animal models of cough: literature review and presentation of a novel cigarette smoke-enhanced cough model in the guinea-pig. Pulm Pharmacol Ther 2007;20:325-33. (Pubitemid 46533942)
19. Lomask M. Further exploration of the Penh parameter. Exp Toxicol Pathol 2006;57(Suppl. 2):13-20. (Pubitemid 43766080)
20. Onoue S, Sato H, Ogawa K, Kojo Y, Aoki Y, Kawabata Y, et al. Inhalable dry-emulsion formulation of cyclosporine A with improved anti-inflammatory effects in experimental asthma/COPD-model rats. Eur J Pharm Biopharm 2012;80:54-60.
21. Mathers RA, Evans GO, Bleby J, Tornow T. Total and differential leucocyte counts in rat and mouse bronchoalveolar lavage fluids using the Sysmex XT-2000iV. Comp Clin Pathol 2007;16:29-39. (Pubitemid 46140346)
22. White SR, Dorscheid DR. Corticosteroid-induced apoptosis of airway epithelium*. Chest 2002;122:278S-84S.
23. Dusser DJ, Djokic TD, Borson DB, Nadel JA. Cigarette smoke induces bronchoconstrictor hyperresponsiveness to substance P and inactivates airway neutral endopeptidase in the guinea pig. Possible role of free radicals. J Clin Invest 1989;84:900-6. (Pubitemid 19228362)
24. Joad JP, Munch PA, Bric JM, Evans SJ, Pinkerton KE, Chen CY, et al. Passive smoke effects on cough and airways in young guinea pigs: role of brainstem substance P. Am J Resp Crit Care 2003 [200308113].
25. Bonham AC, Kott KS, Joad JP. Sidestream smoke exposure enhances rapidly adapting receptor responses to substance P in young guinea pigs. J Appl Physiol 1996;81:1715-22. (Pubitemid 26349630)
26. Mackenzie AJ, Spina D, Page CP. Models used in the development of antitussive drugs. Drug Discov Today 2004;1:297-302. (Pubitemid 41132154)
27. Quint JK, Wedzicha JA. The neutrophil in chronic obstructive pulmonary disease. J Allergy Clin Immunol 2007;119:1065-71. (Pubitemid 46654162)
28. Biernacki WA, Kharitonov SA, Barnes PJ. Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPD. Thorax 2003;58:294-8. (Pubitemid 36411413)
29. Hacievliyagil SS, Gunen H, Mutlu LC, Karabulut AB, Temel I. Association between cytokines in induced sputum and severity of chronic obstructive pulmonary disease. Respir Med 2006;100:846-54.
30. Bradley PP, Priebat DA, Christensen RD, Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 1982;78:206-9. (Pubitemid 12171880)
31. Schols AM, Wesseling G, Kester AD, de Vries G, Mostert R, Slangen J, et al. Dose dependent increased mortality risk in COPD patients treated with oral glucocorticoids. Eur Respir J 2001;17:337-42. (Pubitemid 32600598)
32. McEvoy CE, Niewoehner DE. Adverse effects of corticosteroid therapy for COPD. A critical review. Chest 1997;111:732-43. (Pubitemid 27132953)
33. Kubo S, Kobayashi M, Iwata M, Takahashi K, Miyata K, Shimizu Y. Disease-modifying effect of ASP3258, a novel phosphodiesterase type 4 inhibitor, on subchronic cigarette smoke exposure-induced lung injury in guinea pigs. Eur J Pharmacol 2011;659:79-84.
34. Barnes PJ, Adcock IM. Glucocorticoid resistance in inflammatory diseases. Lancet 2009;373:1905-17.
35. Aoki K, Ishida Y, Kikuta N, Kawai H, Kuroiwa M, Sato H. Role of CXC chemokines in the enhancement of LPS-induced neutrophil accumulation in the lung of mice by dexamethasone. Biochem Biophys Res Commun 2002;294:1101-8. (Pubitemid 34687163)
36. Meagher LC, Cousin JM, Seckl JR, Haslett C. Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. J Immunol 1996;156:4422-8. (Pubitemid 26165843)
37. Serhan CN, Savill J. Resolution of inflammation: the beginning programs the end. Nat Immunol 2005;6:1191-7. (Pubitemid 43045627)
38. Maderna P, Godson C. Lipoxins: resolutionary road. Br J Pharmacol 2009;158:947-59.
39. Levy BD, De Sanctis GT, Devchand PR, Kim E, Ackerman K, Schmidt BA, et al. Multipronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A(4). Nat Med 2002;8:1018-23. (Pubitemid 35033707)
40. Comhair SA, Lewis MJ, Bhathena PR, Hammel JP, Erzurum SC. Increased glutathione and glutathione peroxidase in lungs of individuals with chronic beryllium disease. Am J Respir Crit Care Med 1999;159:1824-9. (Pubitemid 29275050)
41. Lehr HA, Kress E, Menger MD, Friedl HP, Hubner C, Arfors KE, et al. Cigarette smoke elicits leukocyte adhesion to endothelium in hamsters: inhibition by CuZn-SOD. Free Radic Biol Med 1993;14:573-81. (Pubitemid 23172564)
42. Nishikawa M, Kakemizu N, Ito T, Kudo M, Kaneko T, Suzuki M, et al. Superoxide mediates cigarette smoke-induced infiltration of neutrophils into the airways through nuclear factor-kappaB activation and IL-8 mRNA expression in guinea pigs in vivo. Am J Respir Cell Mol Biol 1999;20:189-98. (Pubitemid 129504878)
43. Jeon SM, Bok SH, Jang MK, Kim YH, Nam KT, Jeong TS, et al. Comparison of antioxidant effects of naringin and probucol in cholesterol-fed rabbits. Clin Chim Acta 2002;317:181-90.
44. Rajadurai M, Stanely MPP. Preventive effect of naringin on lipid peroxides and antioxidants in isoproterenol-induced cardiotoxicity in Wistar rats: biochemical and histopathological evidences. Toxicology 2006;228:259-68. (Pubitemid 44708452)
45. Gaur V, Aggarwal A, Kumar A. Protective effect of naringin against ischemic reperfusion cerebral injury: possible neurobehavioral, biochemical and cellular alterations in rat brain. Eur J Pharmacol 2009;616:147-54.